Oruka Therapeutics (ORKA) Institutional Ownership $11.02 -0.26 (-2.30%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$11.00 -0.01 (-0.14%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Oruka Therapeutics (NASDAQ:ORKA)CurrentInstitutional OwnershipPercentage56.44%Number ofInstitutional Buyers(last 12 months)37TotalInstitutional Inflows(last 12 months)$389.58MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$14.30M Get ORKA Insider Trade Alerts Want to know when executives and insiders are buying or selling Oruka Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ORKA Institutional Buying and Selling by Quarter Oruka Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/19/2025 Toronto Dominion Bank58,332$1.13M0.0%N/A0.167% 2/18/2025 Frazier Life Sciences Management L.P.583,327$11.31M0.5%+22.2%1.667% 2/17/2025 VR Adviser LLC3,285,620$63.71M4.4%+6.5%9.387% 2/17/2025 Squarepoint Ops LLC12,175$236K0.0%N/A0.035% 2/17/2025 Toronto Dominion Bank58,332$1.13M0.0%N/A0.167% 2/17/2025 RTW Investments LP1,945,649$37.73M0.6%+5.1%5.559% 2/17/2025 Point72 Asset Management L.P.360,732$7.00M0.0%-25.2%1.031% 2/17/2025 Polar Capital Holdings Plc550,000$10.66M0.1%N/A1.571% 2/17/2025 Paradigm Biocapital Advisors LP819,660$15.89M0.6%+13.9%2.342% 2/17/2025 OMERS ADMINISTRATION Corp19,800$384K0.0%N/A0.057% Get the Latest News and Ratings for ORKA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oruka Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Millennium Management LLC30,305$588K0.0%N/A0.087% 2/17/2025 Janus Henderson Group PLC849,410$16.42M0.0%+259.7%2.427% 2/17/2025Jefferies Financial Group Inc.350,029$6.79M0.0%N/A1.000% 2/17/2025 Fairmount Funds Management LLC3,371,922$65.38M6.5%+5.0%9.634% 2/17/2025 Deep Track Capital LP750,000$14.54M0.5%-39.3%2.143% 2/17/2025 Braidwell LP1,147,676$22.25M0.7%+122.5%3.279% 2/17/2025 Blackstone Inc.240,174$4.66M0.0%N/A0.686% 2/17/2025 Allostery Investments LP20,000$388K0.4%N/A0.057% 2/17/2025 683 Capital Management LLC33,875$657K0.0%N/A0.097% 2/14/2025 Jane Street Group LLC17,706$343K0.0%N/A0.051% 2/14/2025 Northern Trust Corp64,044$1.24M0.0%N/A0.183% 2/14/2025 Adage Capital Partners GP L.L.C.69,200$1.34M0.0%-65.4%0.198% 2/14/2025 Price T Rowe Associates Inc. MD1,326,893$25.73M0.0%+374.5%3.791% 2/14/2025 B Group Inc.20,000$388K0.2%N/A0.057% 2/13/2025 SR One Capital Management LP430,330$8.34M2.0%+14.7%1.230% 2/13/2025 Affinity Asset Advisors LLC368,698$7.15M1.0%+5.4%1.053% 2/13/2025 Barclays PLC74,583$1.45M0.0%N/A0.213% 2/13/2025 Kennedy Capital Management LLC60,494$1.17M0.0%N/A0.173% 2/13/2025 FMR LLC5,512,300$106.88M0.0%+17.7%15.749% 2/12/2025 Geode Capital Management LLC342,418$6.64M0.0%+2,348.6%0.978% 2/12/2025 Wellington Management Group LLP95,089$1.84M0.0%+15.8%0.272% 2/12/2025 JPMorgan Chase & Co.2,800$54K0.0%N/A0.008% 2/11/2025 Vanguard Group Inc.1,610,651$31.23M0.0%+4,161.2%4.602% 2/6/2025 Charles Schwab Investment Management Inc.15,608$303K0.0%N/A0.045% 1/31/2025 AlphaCentric Advisors LLC6,140$119K0.1%N/A0.018% 1/24/2025 China Universal Asset Management Co. Ltd.7,421$144K0.0%N/A0.021% 11/27/2024 Franklin Resources Inc.720,547$17.66M0.0%N/A2.059% 11/16/2024 Geode Capital Management LLC13,984$343K0.0%N/A1.156% 11/15/2024 Frazier Life Sciences Management L.P.477,327$11.70M0.5%N/A39.449% 11/15/2024 Wellington Management Group LLP82,137$2.01M0.0%N/A6.788% Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.You MUST act before March 17th.11/15/2024 RTW Investments LP1,850,648$45.36M0.7%N/A152.946% 11/15/2024 Redmile Group LLC411,728$10.09M0.6%N/A34.027% 11/15/2024 Point72 Asset Management L.P.482,330$11.82M0.0%N/A39.862% 11/15/2024 Janus Henderson Group PLC236,116$5.84M0.0%N/A19.514% 11/14/2024 Braidwell LP515,726$12.64M0.4%N/A42.693% 11/13/2024 Great Point Partners LLC514,659$12.61M3.7%N/A42.534% 11/13/2024 FMR LLC4,682,300$114.76M0.0%N/A386.967% 11/13/2024 The Manufacturers Life Insurance Company42,298$1.04M0.0%N/A3.496% (Data available from 1/1/2016 forward) ORKA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ORKA shares? During the previous two years, 39 institutional investors and hedge funds held shares of Oruka Therapeutics. The most heavily invested institutionals were FMR LLC ($106.88M), Fairmount Funds Management LLC ($65.38M), VR Adviser LLC ($63.71M), RTW Investments LP ($37.73M), Vanguard Group Inc. ($31.23M), Price T Rowe Associates Inc. MD ($25.73M), and Braidwell LP ($22.25M).Learn more on ORKA's institutional investors. What percentage of Oruka Therapeutics stock is owned by institutional investors? 56.44% of Oruka Therapeutics stock is owned by institutional investors. Learn more on ORKA's institutional investor holdings. Which institutional investors have been buying Oruka Therapeutics stock? Of the 37 institutional investors that purchased Oruka Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($5.51M), RTW Investments LP ($1.95M), Vanguard Group Inc. ($1.57M), Braidwell LP ($1.15M), Price T Rowe Associates Inc. MD ($1.05M), Janus Henderson Group PLC ($849.41K), and Franklin Resources Inc. ($720.55K). How much institutional buying is happening at Oruka Therapeutics? Institutional investors have bought a total of 17,443,209 shares in the last 24 months. This purchase volume represents approximately $389.58M in transactions. Which Oruka Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Oruka Therapeutics stock in the last 24 months: Deep Track Capital LP ($485.19K), Adage Capital Partners GP L.L.C. ($130.80K), and Point72 Asset Management L.P. ($121.60K). How much institutional selling is happening at Oruka Therapeutics? Institutional investors have sold a total of 737,585 shares in the last 24 months. This volume of shares sold represents approximately $14.30M in transactions. Related Companies ARQT Institutional Ownership AMPH Institutional Ownership IMCR Institutional Ownership KNSA Institutional Ownership DYN Institutional Ownership GPCR Institutional Ownership ARDX Institutional Ownership INDV Institutional Ownership NRIX Institutional Ownership VIR Institutional Ownership This page (NASDAQ:ORKA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oruka Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oruka Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.